6 European Projects Found
Searched on 125080 European Projects
FINISHED
Hyaluronan-based injectable material for tissue engineering (HYANJI SCAFFOLD) (HYANJI SCAFFOLD)
Start date: Sep 1, 2009, End date: Aug 31, 2013,
"This is an exchange-based programme to enable developing new tissue engineering scaffolds based. It aims at technology transfer of advanced methods from for the biosynthesis of polyalkaonates and for targeted drug delivery. The exchange programme comprises 2 EU partners (Keele and Pisa) and 2 Chinese partners (Tsinghua and Sichuan) who are centres of excellence. The exchange comprises 208 person- ...
Read Project
1
Partner Participant
FINISHED
Disc-degeneration linked pathologies: novel biomarkers and diagnostics for targeting treatment and repair (Genodisc)
Start date: Mar 1, 2008, End date: Feb 28, 2013,
Disorders arising from degeneration of the intervertebral disc are an enormous clinical and financial burden on European societies. Most of the burden arises from 10% of patients who become chronically disabled. Any factor which will improve treatment of back pain sufferers or prevent development of chronic disability would have an important impact both on society and in improving quality of life ...
Read Project
10
Partners Participants
FINISHED
Pheromone Identification for Environmentally Responsible Control of Thrips (PERFECT)
Start date: Jun 1, 2010, End date: May 31, 2012,
"Thrips are insects that are important crop pests in agriculture and horticulture. They cause most damage to protected (greenhouse) crops, which have an annual EU production of 37 billion euros. Growers are struggling to control thrips but are also under pressure to reduce pesticide use. The EU Directive on the Sustainable Use of Pesticides (2009) requires alternatives to pesticides to be used whe ...
Read Project
1
Partner Participant
FINISHED
Role of Stem Cell Products for Alveolar Epithelial Cell Regeneration in Pulmonary Fibrosis (STEMPF)
Start date: Apr 1, 2009, End date: Mar 31, 2011,
"Pulmonary fibrosis (PF) is a progressively debilitating disease of unknown origin, with usual first presentation in 50’s plus age group. Over 500M people are afflicted by this disease world wide; however, this is an underestimate as incidence is rapidly rising as PF becomes better diagnosed. There is currently no efficacious therapeutic intervention which can either halt or reverse the disease pr ...
Read Project
1
Partner Participant
FINISHED
Vector Control for Visceral and Cutaneous Leishmaniasis (VCVCL)
Start date: Oct 7, 2008, End date: Oct 6, 2010,
"Visceral leishmaniasis (VL) & cutaneous leishmaniasis (CL) are parasitic diseases transmitted to humans by the bite of infected insects (sand flies). VL is fatal if not treated and CL may cause facial disfigurement both are more likely to affect children under 15 years old in European as well as S. Mediterranean countries. Precise figures are not available but reports suggest that between 36,000 ...
Read Project
1
Partner Participant
FINISHED
Increasing the PaRticipation of the ElDerly in Clinical Trials (PREDICT)
Start date: Feb 1, 2008, End date: Jul 31, 2010,
"AIM. To investigate the reasons for the exclusion of the elderly in clinical trials and to provide solutions for this problem. INTRODUCTION. Although the elderly account for high drug consumption, they are underrepresented in clinical trials. With an increasingly ageing European population it is essential to demonstrate the efficacy and safety of drugs. Clinical trials need to take into account t ...
Read Project
